<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 15 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): July 17, 1998
NETMED, INC.
(Exact name of Registrant as specified in its charter)
OHIO 1-12529 31-1282391
(State of incorporation (Commission file number) (I.R.S. Employer
or organization) Identification No.)
6189 MEMORIAL DRIVE, DUBLIN, OHIO 43017
(Address of principal executive offices, including zip code)
(614) 793-9356
(Registrant's telephone number, including area code)
<PAGE> 2
ITEM 5.
NETMED EXCHANGE LISTING UNDER REVIEW
On July 17, 1998, NetMed, Inc. announced that it has been advised by
the American Stock Exchange that the company has fallen below certain of the
Exchange's continued listing guidelines and that as a result the Exchange is
reviewing the company's continued listing eligibility. The company plans to meet
with representatives of the Exchange in August to present information in support
of continued listing, but at this time is unable to predict what action will be
taken by the Exchange with respect to the continued listing of the company's
common shares.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Statements in this report which relate to other than strictly historical facts,
including statements about the Company's plans and strategies, as well as
management's expectations about new and existing products, technologies and
opportunities, market growth, demand for and acceptance of new and existing
products (including the PAPNET(R) Testing System and the OxyNet(R) oxygen
concentration device), are forward looking statements. The words "believe,"
"expect," "anticipate," "estimate," "project," and similar expressions identify
forward-looking statements that speak only as of the date hereof. Investors are
cautioned that such statements involve risks and uncertainties that could cause
actual results to differ materially from historical or anticipated results due
to many factors including, but are not limited to, the Company's current
reliance on a single product marketed under license from NSI, the corresponding
dependence on NSI's patents and proprietary technology, government regulation,
continuing losses from operations and negative cash flow, limited marketing and
sales history, the impact of third party reimbursement decisions, the challenges
of research and development of new products, and other risks detailed in the
Company's most recent Annual Report on Form 10-K and other Securities and
Exchange Commission filings. The company undertakes no obligation to publicly
update or revise any forward-looking statements.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized in Dublin, Ohio, on this 21st day of July,
1998.
By: /s/ David J. Richards
------------------------------------
David J. Richards, President
